Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia (2024)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; PONTES, LORENA LÔBO DE FIGUEIREDO - FMRP ; TRAINA, FABÍOLA - FMRP ; MARANI, LETICIA OLOPS - FMRP
- Unidades: FM; FMRP
- DOI: 10.1016/j.htct.2024.02.028
- Subjects: LEUCEMIA MIELOIDE AGUDA; TRANSPLANTE AUTÓLOGO; CÉLULAS-TRONCO; QUIMIOTERAPIA; CUSTOS DE MEDICAMENTOS
- Keywords: Acute myeloid leukaemia; Autologous haematopoietic stem cell transplantation; Consolidation; Chemotherapy; Cost Analysis
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: São José do Rio Preto
- Date published: 2024
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1379
- Volume/Número/Paginação/Ano: v. 46, n. suppl. 6, p. S136-S143, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CHIESA, Sitânia et al. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia. Hematology, Transfusion and Cell Therapy, v. 46, n. suppl. 6, p. S136-S143, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2024.02.028. Acesso em: 09 fev. 2026. -
APA
Chiesa, S., Rego, E. M., Teich, V., Madeira, M. I. A., Figueiredo-Pontes, L. L., Traina, F., & Marani, L. O. (2024). Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia. Hematology, Transfusion and Cell Therapy, 46( suppl. 6), S136-S143. doi:10.1016/j.htct.2024.02.028 -
NLM
Chiesa S, Rego EM, Teich V, Madeira MIA, Figueiredo-Pontes LL, Traina F, Marani LO. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( suppl. 6): S136-S143.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1016/j.htct.2024.02.028 -
Vancouver
Chiesa S, Rego EM, Teich V, Madeira MIA, Figueiredo-Pontes LL, Traina F, Marani LO. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( suppl. 6): S136-S143.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1016/j.htct.2024.02.028 - Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia
- High frequency of leukemic stem cells is associated with adverse prognosis in a Brazilian cohort of acute myeloid leukemia with normal karyotype
- Padronização de diferentes metodologias para investigação molecular da presença da mutação JAK2V616F em pacientes com neoplasia mieloide na FMRP USP
- Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia [Carta]: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-trans retinoic acid
- Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta]
- Estabelecimento de um protocolo de doença residual mínima por citometria de fluxo multiparamétrica em pacientes com leucemia mieloide aguda
- Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy
- Association of natural killer cells functional subtypes with genetic risk stratification in acute myeloid leukemia
- Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells
- Reversine triggers mitotic catastrophe and apoptosis in BCR-ABL positive cells
Informações sobre o DOI: 10.1016/j.htct.2024.02.028 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
